Get an alert when SEED NEWCO LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2027-03-31 (in 10mo)

Last filed for 2025-06-30

Confirmation statement due

2026-06-11 (in 1mo)

Last made up 2025-05-28

Watchouts

None on the register

Cash

Latest balance sheet

Net assets

£596K

+2.3% vs 2024

Employees

Average over period

Profit before tax

Period ending 2025-06-30

Accounts

6-year trend · latest reflected 2025-06-30

Metric Trend 2020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Turnover
Operating profit
Profit before tax
Net profit
Cash
Total assets less current liabilities
Net assets £582,455£596,089
Equity £578,681£576,431£574,556£572,681£582,455£596,089
Average employees
Wages

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Consolidated group
Auditor
Hazlewoods LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“After reviewing the group's forecasts and projections, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. The group therefore continues to adopt the going concern basis in preparing its financial statements.”

Group structure

  1. SEED NEWCO LIMITED · parent
    1. Seed Bidco Limited 100% · England and Wales · holding company
    2. BXTAccelyon Limited 100% · England and Wales · supply of devices for the diagnosis and treatment of prostate cancer
    3. BXTAccelyon NZ Limited 100% · New Zealand · supply of devices for the diagnosis and treatment of prostate cancer
    4. BXTAccelyon Australia Pty Limited 100% · Australia · supply of devices for the diagnosis and treatment of prostate cancer
    5. BXTAccelyon NL BV 100% · Netherlands · supply of devices for the diagnosis and treatment of prostate cancer
    6. BXTAccelyon France SARL 100% · France · supply of devices for the diagnosis and treatment of prostate cancer
    7. BXTAccelyon Iberia S.L. 100% · Spain · supply of devices for the diagnosis and treatment of prostate cancer
    8. BXTA Nanotherapy Ltd 69.5% · England and Wales · research and development of new treatments and diagnostic devices of prostate cancer

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 1 resigned

Name Role Appointed Born Nationality
BRETT, Edward James Timothy Director 2013-05-28 Mar 1967 British
HUGHES, Malcolm Keith Director 2013-08-02 Jul 1954 British
RASHID, Saheed Director 2013-08-02 Mar 1962 British
TERRY, Kenneth John Director 2013-05-28 May 1964 British
Show 1 resigned officer
Name Role Appointed Resigned
MCCOY, Laura Jane Director 2013-08-01 2017-03-28

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Elysian Capital Gp (Scotland) Limited Corporate entity Significant influence 2016-04-06 Active

Filing timeline

Last 20 of 49 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2018-11-28 RESOLUTIONS Resolution
Date Type Category Description
2026-02-06 AA accounts Accounts with accounts type group PDF
2025-06-26 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-03-05 AA accounts Accounts with accounts type group PDF
2024-06-24 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-03-27 AA accounts Accounts with accounts type group PDF
2023-06-21 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-03-30 AA accounts Accounts with accounts type group PDF
2022-06-07 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-03-31 AA accounts Accounts with accounts type small PDF
2021-06-28 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-04-21 AA accounts Accounts with accounts type small PDF
2021-01-27 CH01 officers Change person director company with change date PDF
2020-07-09 CS01 confirmation-statement Confirmation statement with no updates PDF
2020-04-23 AA accounts Accounts with accounts type small PDF
2019-06-10 CS01 confirmation-statement Confirmation statement with updates PDF
2019-04-03 AA accounts Accounts with accounts type small
2018-11-28 RESOLUTIONS resolution Resolution
2018-11-13 SH20 capital Legacy
2018-11-13 SH19 capital Capital statement capital company with date currency figure
2018-11-13 CAP-SS insolvency Legacy

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
2

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2024 → FY2025 · period ending 2025-06-30 vs 2024-06-30

Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers

Official Companies House page